First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases

Clinical trial NCT05599945 · COMPLETED

Trial details

NCT number: NCT05599945
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Hepatic Steatosis

Start date: 2022-11-23
Primary completion: 2025-08-29
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.